sever
acut
respiratori
syndrom
sar
highli
infecti
diseas
caus
novel
coronaviru
sarscov
specif
monoclon
antibodi
mab
sarscov
vital
earli
diagnosi
patholog
studi
sar
direct
intrasplen
inocul
plasmid
dna
encod
antigen
effect
fast
approach
gener
specif
mab
protein
antigen
difficult
prepar
danger
use
studi
select
one
fragment
sarscov
spike
protein
antigen
determin
immunoinformat
singl
intrasplen
immun
plasmid
dna
encod
induc
antispik
protein
antibodi
establish
one
hybridoma
cell
line
secret
specif
mab
evalu
mab
murin
leukemia
viru
pseudotyp
sarscov
spike
protein
mlvsarscov
mab
could
recogn
spike
protein
mlvsarscovinfect
vero
cell
albeit
neutral
effect
infect
pseudotyp
viru
result
show
singleshot
intrasplen
dna
immun
effici
product
specif
mab
sar
spike
protein
linear
epitop
spike
protein
recogn
studi
sever
acut
respiratori
syndrom
sar
highli
infecti
atyp
pneumonia
proxim
mortal
infect
case
etiolog
analysi
identifi
novel
coronaviru
name
sarsassoci
coronaviru
sarscov
sarscov
spike
protein
major
determin
pathogenesi
main
target
protect
immun
respons
compos
two
noncoval
associ
domain
ntermin
domain
respons
viral
attach
cellular
receptor
membranespan
fragment
domain
take
part
host
cell
entri
infect
cellcel
fusion
recent
angiotensinconvert
enzym
identifi
function
receptor
sarscov
neutral
human
monoclon
antibodi
block
bind
domain
sensit
vero
cell
domain
locat
within
ntermin
residu
aa
spike
protein
higher
affin
full
domain
residu
aa
consid
high
infect
sarscov
simpl
fast
diagnosi
sar
case
crucial
prevent
outbreak
sinc
human
sar
antibodi
emerg
week
onset
symptom
develop
specif
monoclon
antibodi
mab
sarscov
spike
protein
vital
earli
diagnosi
even
neutral
sarscov
infect
shown
singl
intrasplen
inject
plasmid
dna
encod
foreign
protein
provid
effect
fast
method
gener
specif
mab
splenocyt
includ
antigenpres
cell
directli
transfect
inject
plasmid
dna
express
antigen
concentr
spleen
initi
immun
respons
promptli
studi
perform
singl
intrasplen
immun
plasmid
dna
encod
one
fragment
domain
sarscov
spike
protein
establish
specif
mab
short
time
evalu
mab
murin
leukemia
viru
pseudotyp
sarscov
spike
protein
mlvsarscov
mab
could
recogn
spike
protein
vero
cell
infect
mlvsarscov
neutral
effect
infect
pseudotyp
viru
mous
myeloma
cell
line
cultur
medium
supplement
fetal
calf
serum
fc
human
kidney
cell
african
green
monkey
kidney
vero
cell
maintain
dulbecco
modifi
eagl
medium
gibco
brl
gaithersburg
md
contain
fc
cell
incub
c
humidifi
atmospher
co
antigen
determin
domain
sar
spike
protein
genbank
access
close
match
coronavirus
predict
protean
dnastar
lasergen
program
packag
select
appropri
peptid
sequenc
take
account
hydrophil
hydrophob
surfac
probabl
chain
flexibl
antigen
index
secondari
structur
polypeptid
residu
aa
atstgnynykyrylrhgklrpferd
potent
antigen
site
synthes
convent
solidphas
chemistri
abi
pioneer
model
peptid
synthes
gene
encod
polypeptid
synthes
two
dna
oligonucleotid
sequenc
follow
ttc
gga
tcc
acc
atg
gct
act
tca
act
ggt
aat
tat
aat
tat
aaa
tat
agg
tat
ctt
aga
cat
ggc
aag
ctt
agg
ccc
tttgag
aga
gac
taa
ctc
gag
sens
gaa
ctc
gag
tta
gtc
tct
ctc
aaa
ggg
cct
aag
ctt
gcc
atg
tct
aag
ata
cct
ata
ttt
ata
att
ata
att
acc
agt
tga
agt
agc
cat
ggt
gga
tcc
antisens
kozak
consensu
sequenc
plu
initi
codon
stop
codon
ad
end
respect
two
dna
oligonucleotid
sequenc
anneal
insert
bamhixhoi
site
vector
invitrogen
sequenc
confirm
plasmid
intrasplen
immun
prepar
use
endofre
plasmid
kit
qiagen
hilden
germani
intrasplen
dna
immun
perform
previous
describ
modif
briefli
male
balbc
mice
anesthet
via
intraperiton
inject
pentobarbit
mgkg
small
dissect
skin
left
abdomen
perform
expos
spleen
one
hundr
microlit
plasmid
gl
deepli
inject
spleen
peritoneum
skin
sutur
mice
special
care
blood
sampl
collect
tail
bleed
everi
day
sera
separ
store
c
seven
day
immun
spleen
cell
suspens
hyperimmun
mice
fuse
myeloma
cell
hypoxanthineaminopterinthimidin
hat
select
cultur
hybridoma
cultur
supernat
analyz
antibodi
polypeptid
elisa
one
posit
primari
hybridoma
term
subclon
three
round
limit
dilut
isotyp
monoclon
antibodi
determin
isotyp
elisa
kit
pierc
chemic
co
rockford
il
ascit
fluid
induc
monoclon
hybridoma
cell
produc
male
balbc
mice
store
c
chimer
mlvsar
pseudotyp
viru
gener
cotransfect
cell
three
plasmid
gagpol
egfpmlv
gift
dr
wen
hui
li
partner
aid
research
center
harvard
medic
school
boston
calcium
phosphat
treatment
plasmid
modifi
encod
cytoplasm
domain
truncat
codonoptim
spike
protein
viral
supernat
harvest
h
posttransfect
concentr
ultrafiltr
produc
cell
pellet
store
western
blot
assay
viral
stock
frozen
c
titer
gfp
express
mlvsarscovinfect
vero
cell
flow
cytometri
dilut
immun
murin
antisera
hybridoma
supernat
ascit
assay
elisa
briefli
elisa
plate
corn
costar
cambridg
mass
coat
g
synthet
incub
sampl
wash
bound
antibodi
detect
hrpconjug
goat
antimous
igg
h
l
secondari
antibodi
kpl
gaithersburg
md
color
tm
turbo
tmb
elisa
reagent
pierc
chemic
co
rockford
il
serum
nonimmun
mice
hybridoma
growth
medium
use
neg
control
investig
whether
antibodi
could
react
nativ
sarscov
spike
protein
posit
hybridoma
supernat
evalu
sar
viral
lysat
elisa
kit
huada
gbi
biotech
beij
china
recommend
second
antibodi
antihuman
igg
replac
hrpconjug
goat
antimous
igg
h
l
second
antibodi
produc
cell
lyse
h
transfect
sampl
separ
sdspage
gel
electrotransf
pvdf
membran
immunoblot
assay
perform
hybridoma
supernat
hrpconjug
goat
antimous
igg
h
l
second
antibodi
specif
band
visual
ecl
system
amersham
braunschweig
germani
mlvsarscovinfect
vero
cell
cytospin
prepar
fix
cold
methanolaceton
block
goat
serum
incub
dilut
mab
ascit
primari
antibodi
wash
cell
incub
fitcconjug
goat
antimous
igm
santa
cruz
biotechnolog
santa
cruz
ca
min
dark
observ
invert
fluoresc
microscop
determin
whether
mab
could
block
infect
mlvsarscov
neutral
assay
perform
describ
vero
cell
infect
mlvsarscov
preincub
serial
dilut
hybridoma
ascit
two
day
later
percentag
gfpexpress
cell
detect
flow
cytometri
sar
acut
respiratori
diseas
caus
newli
identifi
coronaviru
sarscov
spike
protein
sarscov
play
crucial
role
viral
entri
host
cell
therefor
becom
major
target
neutral
antibodi
prepar
specif
monoclon
antibodi
sarscov
spike
protein
make
import
earli
diagnosi
viral
pathogenesi
studi
vaccin
develop
special
biosafeti
facil
purifi
sarscov
viral
lysat
high
infecti
potenti
commonli
use
immunogen
antisar
antibodi
prepar
two
recent
report
develop
dna
vaccin
sar
n
protein
truncat
spike
protein
shown
induc
specif
antibodi
cytotox
lymphocyt
ctl
gener
two
three
time
intramuscular
dna
immun
sever
month
develop
mab
sarscov
singleshot
intrasplen
immun
plasmid
dna
encod
one
fragment
domain
spike
protein
short
time
instead
hazard
wildtyp
sarscov
chimer
mlvsarscov
pseudotyp
viru
use
character
mab
immunoinformat
analyz
domain
sarscov
spike
protein
select
fragment
residu
aa
immunogen
plasmid
dna
encod
inject
directli
spleen
balbc
mice
trigger
immunolog
reaction
antisera
analyz
elisa
plate
coat
synthet
polypeptid
sarscov
lysat
preliminari
experi
intraspleen
immun
mice
show
posit
immun
respons
day
sera
titer
peak
day
much
faster
protein
intramuscular
dna
immun
therefor
perform
hybridoma
fusion
day
intraspleen
inject
investig
demonstr
possibl
obtain
good
hybridoma
product
within
short
immun
time
irrespect
antibodi
respons
intrasplen
immun
anim
antibodi
respons
immun
mice
crucial
determin
express
antigen
transfect
spleen
cell
concern
natur
trait
encod
antigen
express
vector
use
hybridoma
clone
subclon
mab
determin
igm
isotyp
cultur
supernat
ascit
recogn
synthet
polypeptid
specif
elisa
assay
also
establish
mab
sarscov
nucleoprotein
n
protein
singleshot
intrasplen
inocul
plasmid
encod
epitop
residu
aa
n
protein
specif
antin
antibodi
could
detect
mice
day
elisa
kit
coat
synthet
n
protein
fragment
sarscov
lysat
data
shown
data
suggest
spike
protein
fragment
n
protein
potent
epitop
singl
intrasplen
inject
eukaryot
express
plasmid
code
antigen
effici
induc
specif
antibodi
short
time
much
faster
protein
intramuscular
dna
immun
sarscov
highli
contagi
must
handl
stringent
protect
util
mlvsarscov
pseudotyp
viru
evalu
mab
mlv
pseudotyp
viru
could
inherit
new
cell
tropism
envelop
protein
donat
viru
studi
genom
mlv
pseudotyp
carri
sarscov
spike
protein
gfp
report
gene
viral
supernat
transfect
cell
concentr
titer
iuml
mlvsarscov
could
infect
sarscovsuscept
vero
cell
sinc
giant
multinucl
vero
cell
egfp
fluoresc
appear
infect
fig
titer
also
determin
percentag
gfpposit
vero
infect
investig
specif
mab
supernat
hybridoma
cell
use
primari
antibodi
probe
lysat
mlvsarscovinfect
cell
band
mw
kda
detect
fig
signal
observ
mocktransfect
cell
suggest
mab
could
specif
recogn
spike
protein
spike
protein
typei
membran
protein
portion
spike
protein
unincorpor
bud
virion
transport
plasma
membran
infect
cell
determin
whether
mab
recogn
spike
protein
space
mab
use
primari
antibodi
detect
spike
protein
mlvsarscovinfect
vero
cell
shown
fig
posit
signal
predomin
plasma
membran
infect
vero
cell
wherea
signal
noninfect
cell
data
suggest
mab
could
recogn
spike
protein
infect
cell
surfac
explor
whether
mab
could
block
combin
sar
spike
protein
receptor
preincub
mlvsarscov
show
infect
vero
cell
differ
percentag
gfpposit
cell
infect
compar
untreat
mlvsarscov
data
shown
epitop
specif
antibodi
bind
usual
five
eight
amino
acid
residu
surfac
antigen
epitop
recogn
antibodi
may
correspond
simpl
primari
sequenc
structur
specif
threedimension
antigen
conform
mab
suitabl
western
blot
immunofluoresc
assay
fail
reduc
infect
mlvsarscov
suggest
nonneutr
mab
may
recogn
linear
epitop
conform
one
conclus
develop
monoclon
antibodi
sarscov
spike
protein
singleshot
intrasplen
dna
immun
intrasplen
dna
immun
rout
might
shed
light
product
polyclon
monoclon
antibodi
exigu
antigen
difficult
prepar
danger
use
futur
sarscov
studi
neutral
antibodi
spike
protein
gener
effici
approach
possibl
therapeut
purpos
